Regenxbio
RGNX
66 hedge funds and large institutions have $247M invested in Regenxbio in 2015 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 9 closing their positions.
200% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 9
38% more funds holding
Funds holding: 48 → 66 (+18)
33% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 12
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less capital invested
Capital invested by funds: $310M → $247M (-$63M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
+$6.98M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.61M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.87M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.44M |
| 5 |
JP Morgan Chase
New York
|
+$2.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VM
VHCP Management
New York
|
-$20.5M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$6.1M |
| 3 |
GAMA
Graticule Asia Macro Advisors
New York
|
-$4.53M |
| 4 |
DM
Deerfield Management
New York
|
-$3.32M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$3.11M |
RGNX Hedge Fund Activity: Q4 2015 in Review
66 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q4 2015, worth a combined $247M — down 20% from $310M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new RGNX positions and 9 closed out — a net gain of 18 holders — while 16 added to existing stakes and 12 trimmed.
The largest buyer was QVT Financial, opening a new position worth an estimated $6.98M. The largest seller was VHCP Management, cutting an estimated $20.5M.
- 66 institutional investors held Regenxbio (RGNX) as of Q4 2015, up from 48 in Q3 2015.
- Funds reported $247M of Regenxbio stock for Q4 2015, down 20% quarter-over-quarter.
- 27 funds opened new Regenxbio positions in Q4 2015 and 9 closed out, a net change of +18 holders.
- The largest Regenxbio buyer in Q4 2015 was QVT Financial, an estimated $6.98M added.
- The largest Regenxbio seller in Q4 2015 was VHCP Management, an estimated $20.5M sold.
Based on aggregated 13F filings for Q4 2015.